Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy (BIOFER12)

Fondazione Italiana Sindromi Mielodisplastiche-ETS

Status: Completed

Conditions: Myelofibrosis; Myelodysplasia; Aplastic Anemia

Study type: Observational

Funder types: Other

Identifiers

NCT01956799

FISM-BIOFER12

Details and patient eligibility

About

The study aims to evaluate the molecular mechanism underlying the erythroid response observed in some patients with myelodysplasia, myelofibrosis and aplastic anemia treated with Deferasirox or Deferoxamina.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients aged 18 and older
2. Diagnosis of Myelodysplasia, myelofibrosis or aplastic anemia
3. transfusion-dependent anemia undergoing chelation therapy with deferasirox or deferoxamine

Exclusion criteria

• none